Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-14 Purchase | 2025-03-19 7:40 pm | OptimizeRx Corp | OPRX | Lang James Paul Director | 321,408 | $7.6033 | $2,443,761 | 389,452 (Direct) | View |
| 2022-08-19 Purchase | 2022-08-23 4:45 pm | OptimizeRx Corp | OPRX | Lang James Paul Director | 6,000 | $16.45 | $98,723 | 38,660 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-05 Option Award | 2026-01-09 5:00 pm | N/A 2031-01-05 | BIOVIE INC. | BIVI | Lang James Paul Director | 420,500 | $0 | 420,500 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 6:56 pm | N/A 2036-01-02 | HALOZYME THERAPEUTICS INC. | HALO | Lang James Paul Director | 2,231 | $0 | 2,231 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-12 4:35 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 9,868 | $0 | 399,320 (Direct) | View |
| 2024-11-20 Option Award | 2025-01-07 5:19 pm | N/A 2029-11-20 | BIOVIE INC. | BIVI | Lang James Paul Director | 84,290 | $0 | 84,290 (Direct) | View |
| 2024-06-05 Exercise | 2024-06-11 5:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 10,061 | $0 | 68,044 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 5:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 13,286 | $0 | 68,044 (Direct) | View |
| 2023-11-09 Option Award | 2023-12-06 4:16 pm | N/A 2028-11-09 | BIOVIE INC. | BIVI | Lang James Paul Director | 93,500 | $0 | 93,500 (Direct) | View |
| 2023-06-07 Exercise | 2023-08-18 09:31 am | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 4,637 | $0 | 54,758 (Direct) | View |
| 2023-06-07 Option Award | 2023-08-18 09:31 am | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 10,061 | $0 | 54,758 (Direct) | View |
| 2023-03-30 Exercise | 2023-04-03 12:22 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 657 | $0 | 40,717 (Direct) | View |
| 2022-11-23 Option Award | 2023-01-18 4:25 pm | N/A N/A | BIOVIE INC. | BIVI | Lang James Paul Director | 43,578 | $0 | 68,622 (Direct) | View |
| 2022-12-30 Exercise | 2023-01-04 4:04 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 409 | $0 | 39,403 (Direct) | View |
| 2022-09-29 Exercise | 2022-09-30 4:46 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 334 | $0 | 38,994 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 4,637 | $0 | 4,637 (Direct) | View |
| 2022-04-05 Option Award | 2022-04-25 11:48 am | N/A 2032-04-05 | BIOVIE INC. | BIVI | Lang James Paul Director | 127,900 | $0 | 127,900 (Direct) | View |
| 2022-03-30 Option Award | 2022-04-01 4:48 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 657 | $0 | 657 (Direct) | View |
| 2021-12-30 Option Award | 2022-01-03 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 409 | $0 | 743 (Direct) | View |
| 2021-09-29 Option Award | 2021-10-01 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 334 | $0 | 334 (Direct) | View |
| 2021-06-30 Option Award | 2021-06-30 4:48 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 407 | $0 | 32,660 (Direct) | View |
| 2021-03-31 Option Award | 2021-04-02 12:38 pm | N/A N/A | OptimizeRx Corp | OPRX | Lang James Paul Director | 539 | $0 | 32,253 (Direct) | View |